Regulation (EU) 2015/2283 has classified CBD as a novel food across the EU since January 2019. To date, no member state holds Union list authorisation for it. EFSA's February 2026 provisional safe intake figure (roughly 2mg/day for a 70kg adult) is a safety opinion, not an authorisation.
Lithuania is not a narcotics-law country for hemp, and that surprises most readers. The Law on the Control of Narcotic and Psychotropic Substances states in its opening provisions that it does not apply to fibre hemp regulated by the Law on Fibre Hemp. The health ministry's schedules, which do list cannabis extracts and tinctures as a material, are made under that law, so they cannot reach material the parent statute has removed from its own scope. Neither cannabidiol nor cannabinol is named anywhere in any of the four schedules. This is the cleanest statutory carve-out of any country we track.
The carve-out is conditional rather than absolute. It holds only for hemp that qualifies under the Law on Fibre Hemp, which means a variety entered in the EU Common Catalogue or the national list, and no more than 0.3 per cent THC in the dried material.
What actually bars a CBD supplement in Lithuania is food law, in two layers. The Law on Fibre Hemp applies the Novel Food Regulation directly, and the food and veterinary service states that foods containing fibre hemp extracts or constituents obtained from them, cannabidiol expressly among them, cannot be supplied to the Lithuanian market. Separately, a joint order of the Ministers of Health and Agriculture in force since 1 April 2023 caps THC in fibre hemp food supplements at 2 mg per kilogram of finished product, measured as combined delta-9-THC and delta-9-THCA. That is a far tighter figure than any percentage-based rule elsewhere in the EU.
Breach of the market-supply rules is an administrative matter, not a criminal one, and carries administrative fines in the hundreds of euros, doubling on repetition within a year.